News + Filings Transactions
All All (ex-4s) 10-K 10-Q 8-K 3,4,5 Proxy Prospectus Other
|
Butchko Julia G.
|
Create: Alert |
All | News | Filings
Date Filed | Type | Description |
10/06/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 296 shares
@ $35.54, valued at
$10.5k
Sold 1,439 shares
@ $36.39, valued at
$52.4k
|
|
08/25/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 12,332 shares
@ $20.3, valued at
$250.3k
Sold 1 shares
@ $20.89, valued at
$20.9 |
|
07/13/2023 |
4
| Butchko Julia G. (Chief Development Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 1,470 shares
@ $19.73, valued at
$29k
|
|
04/19/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/14/2023 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
01/13/2023 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 19 shares
@ $15.16, valued at
$288 Sold 60,471 shares
@ $16.79, valued at
$1M
|
|
10/17/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 928 shares
@ $9.18, valued at
$8.5k
|
|
09/29/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 535 shares
@ $4.67, valued at
$2.5k
|
|
09/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
08/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/29/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
07/01/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
05/25/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
04/29/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 541 shares
@ $4.72, valued at
$2.6k
|
|
04/14/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 6,381 shares
@ $5.9, valued at
$37.6k
|
|
01/11/2022 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Sold 55,318 shares
@ $7.25, valued at
$401.1k
|
|
09/14/2021 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Granted 319,700 options to buy
@ $8.62, valued at
$2.8M
Disposed/sold 319,700 options to buy
@ $19.01, valued at
$6.1M
Granted 191,100 options to buy
@ $8.62, valued at
$1.6M
Disposed/sold 191,100 options to buy
@ $17, valued at
$3.2M
|
|
03/23/2021 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Granted 54,500 shares
@ $0 Granted 191,100 options to buy
@ $17, valued at
$3.2M
|
|
09/15/2020 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Bought 5,000 shares
@ $38.17, valued at
$190.9k
|
|
05/18/2020 |
4
| Butchko Julia G. (Chief Dev. & Tech. Officer) has filed a Form 4 on Immunovant, Inc.
Txns:
| Granted 319,700 options to buy
@ $19.01, valued at
$6.1M
|
|
12/20/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
12/20/2019 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
|
|